Project Grant G2640089

This federal Project Grant award of $1,499,606.00 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to characterize health outcomes and identify disparities in children born to people with opioid use disorder (OUD) from birth to 5 years of age. The study will utilize data from the Texas Neonatal Care Research Collaborative to: Examine variation in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across hospitals and identify...

The United Way of Rutherford County, Inc. was awarded a $2,250,000 Rural Communities Opioid Response Program-Impact grant by the Federal Office of Rural Health Policy (CFDA 93.155 Rural Health Research Centers) to demonstrate the effectiveness of telehealth networks in delivering rural emergency and neonatal services. The 4-year grant, awarded on September 1, 2024, aims to address critical rural healthcare challenges, with a focus on opioid response and improving access to services for...

This $3,900,000 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493) is intended to expand the capacity of the NOWS-NM Quality Improvement (QI) Program in New Mexico. The program aims to optimize care and support for infants with neonatal opioid withdrawal syndrome (NOWS) and their families, particularly in rural and underserved areas of the state. Key activities funded under this grant...

This $180,059 Project Grant award was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research by the Research Institute at Nationwide Children's Hospital (RINCH) to identify positive childhood experiences (PCEs) that can promote optimal developmental outcomes in children with a history of neonatal opioid withdrawal syndrome (NOWS). The key products and services to be delivered under this 5-year award...

This federal Project Grant award in the amount of $945,397, awarded by the National Institute on Drug Abuse under CFDA 93.279 "Drug Use and Addiction Research Programs", supports research to adapt and evaluate the impact of a collaborative care model (CCM) for pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt an existing CCM for rural and low-resource obstetric settings, 2) create a common data model to harmonize...

The Rural Communities Opioid Response-Implementation Project Grant was awarded on September 1, 2021 by the Department of Health and Human Services Health Resources and Services Administration (HRSA) to Foothills Academy Inc. located in Monticello, KY. With total funding of $2,000,000, this three-year award through August 31, 2024 supports telehealth services under the Telehealth Programs (CFDA 93.211) federal grant program. The purpose of the Telehealth Programs is to fund initiatives...

This $3,000,000 Project Grant award from the Federal Office of Rural Health Policy (CFDA 93.155 - Rural Health Research Centers program) supports the "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT" initiative led by Centerstone of Indiana Inc., a non-profit behavioral healthcare provider. The grant will fund a 4-year project from September 2024 to August 2028 focused on addressing the opioid crisis in rural communities. Key products and services to be delivered include...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

The Wilson County Substance Abuse Coalition was awarded a $2,248,167 federal Project Grant from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155). The grant will fund the coalition's "Rural Communities Opioid Response Program-IMPACT" initiative from September 1, 2024 through August 31, 2028. The project aims to address substance abuse and mental health challenges in rural...

The National Institute on Drug Abuse (NIDA) awarded a $3,503,736 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Seattle Children's Hospital. The 2-year R61 phase will co-design a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county legal systems. In the subsequent 3-year R33 phase, the strategy will be tested through a hybrid stepped wedge trial across 15 counties to assess implementation and...